BUSINESS

Comparison of subtypes of skin melanoma in the United States and China

US

5%

1%

24%

Melanoma Subtypes:

Chronic Sun Exposure

China

20%

Non-Chronic Sun Exposure

7%

50%

70%

Acral

Mucosal

23%

Source:

ASCO 2018

Optimal tumor shrinkage rate in advanced melanoma patients treated with JS001

Source:

ASCO 2018

As shown in the further subgroup analysis, efficacy in PD-L1 positive melanoma tumor
patients was better than in the negative patients. The ORR of 24 PD-L1 positive tumor patients
and 80 PD-L1 negative tumor patients were 45.8% and 15.0%, respectively.

– 200 –

